Cardiovascular and Metabolism

Metabolic disorders describes a large class of diseases, including heart disease and diabetes, that involve an imbalance in proteins, lipids, carbohydrates, or nucleic acids.  Our current clinical program in metabolic diseases focuses on cardiovascular disease, the number one cause of morbidity and mortality in the United States and other developed countries.

Robert Pordy Robert Pordy, M.D., FACP VP Clinical Sciences Cardiovascular and Metabolism

Clinical Trials

Regeneron has investigational product candidates progressing through all stages of human clinical trials.

See if there are clinical trials that might be right for you


This section discusses pipeline drug candidates currently undergoing clinical testing in a variety of diseases. The safety and efficacy of these drug candidates have not been evaluated by any regulatory authorities for the indications described in this section.

Form content here please :)